Literature DB >> 8710213

A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampus.

M Yoshino1, S Sawada, C Yamamoto, H Kamiya.   

Abstract

The effects of specific metabotropic glutamate receptor (mGluR) agonists on field excitatory postsynaptic potentials (fEPSPs) at mossy fiber-CA3 synapses were examined in guinea pig hippocampal slice preparations. Application of a novel and potent group II-selective mGluR agonist (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine (DCG-IV; 0.1 microM) reversibly reduced the fEPSPs. Both the group III-selective agonist DL-2-amino-4-phosphonobutyric acid (AP4; 50 microM) and the broad-spectrum agonist 1S,3R-1-aminocyclopentane-1, 3-dicarboxylic acid (1S,3R-ACPD; 5 microM) also reversibly suppressed the fEPSPs. These results suggest that multiple mGluR subtypes (belonging to groups II and III) are expressed at mossy fiber synapses of the guinea pig hippocampus and activation of the receptors reduces the synaptic excitation, although we cannot exclude the possibility that guinea pig mossy fiber-CA3 synapses express a single class of mGluRs with unique pharmacological profiles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710213     DOI: 10.1016/0304-3940(96)12486-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Synapse-specific adaptations to inactivity in hippocampal circuits achieve homeostatic gain control while dampening network reverberation.

Authors:  Jimok Kim; Richard W Tsien
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

Review 2.  mGluRs modulate strength and timing of excitatory transmission in hippocampal area CA3.

Authors:  Kathleen E Cosgrove; Emilio J Galván; Germán Barrionuevo; Stephen D Meriney
Journal:  Mol Neurobiol       Date:  2011-05-11       Impact factor: 5.590

3.  CB1 receptor antagonism impairs the induction of epileptiform activity by group I metabotropic glutamate receptor activation.

Authors:  Linda Karr; Yu-Zhen Pan; Paul A Rutecki
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

Review 4.  Metabotropic glutamate receptors as therapeutic targets for schizophrenia.

Authors:  Paige N Vinson; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2011-05-19       Impact factor: 5.250

5.  Control of CA3 output by feedforward inhibition despite developmental changes in the excitation-inhibition balance.

Authors:  Christine L Torborg; Toshiaki Nakashiba; Susumu Tonegawa; Chris J McBain
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

6.  High affinity group III mGluRs regulate mossy fiber input to CA3 interneurons.

Authors:  Kathleen E Cosgrove; Stephen D Meriney; Germán Barrionuevo
Journal:  Hippocampus       Date:  2010-09-07       Impact factor: 3.899

7.  GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Authors:  Emilio R Garrido Sanabria; Krystyna M Wozniak; Barbara S Slusher; Asaf Keller
Journal:  J Neurophysiol       Date:  2003-08-13       Impact factor: 2.714

8.  Testosterone depletion in adult male rats increases mossy fiber transmission, LTP, and sprouting in area CA3 of hippocampus.

Authors:  Vanessa A Skucas; Aine M Duffy; Lauren C Harte-Hargrove; Alejandra Magagna-Poveda; Thomas Radman; Goutam Chakraborty; Charles E Schroeder; Neil J MacLusky; Helen E Scharfman
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

9.  Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated.

Authors:  Jennifer E Ayala; Colleen M Niswender; Qingwei Luo; Jessica L Banko; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2007-12-24       Impact factor: 5.250

Review 10.  cAMP-Dependent Synaptic Plasticity at the Hippocampal Mossy Fiber Terminal.

Authors:  Meishar Shahoha; Ronni Cohen; Yoav Ben-Simon; Uri Ashery
Journal:  Front Synaptic Neurosci       Date:  2022-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.